AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
-32.2%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$11.8M
AUM Growth
+$11.8M
(-36%)
Cap. Flow
-$7.39M
Cap. Flow
% of AUM
-62.88%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$2.13M |
Top Sells
| 1 |
Synlogic
SYBX
|
$6.96M |
| 2 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$2.56M |
Sector Composition
| 1 | Communication Services | 61.07% |
| 2 | Healthcare | 38.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Skillz
SKLZ
$135M
| $5.84M | 49.69% | 1,145,492 | – | – |
|
|
2
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $2.13M | 18.08% | +568,408 | New | +$2.13M |
|
3
Spero Therapeutics
SPRO
$116M
| $1.64M | 13.93% | 1,353,303 | – | – |
|
4
Snap
SNAP
$12.1B
| $1.34M | 11.38% | 150,160 | – | – |
|
|
5
Synlogic
SYBX
$17M
| $497K | 4.23% | 176,798 -2,475,165 | -93% | -$6.96M |
|
6
Intellia Therapeutics
NTLA
$1.22B
| $316K | 2.69% | 10,000 | – | – |
|
|
SURF
7
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| – | – | -2,945,453 | Closed | -$2.56M |
|